Spiess BD - Search Results

1

Case 1-2008. One institution's decreasing use of aprotinin during cardiac surgery in 2006.

Strouch ZY, Chaney MA, Augoustides JG, Spiess BD. Strouch ZY, et al. Among authors: spiess bd. J Cardiothorac Vasc Anesth. 2008 Feb;22(1):139-46. doi: 10.1053/j.jvca.2007.11.005. J Cardiothorac Vasc Anesth. 2008. PMID: 18249349 No abstract available.

2

CASE 4-2014: ascending aortic pseudoaneurysm repair with deep hypothermic circulatory arrest in an adult congenital heart disease patient with heparin-induced thrombocytopenia.

Maxwell BG, Harrington KB, Hill CC, Banayan JM, Spiess BD. Maxwell BG, et al. Among authors: spiess bd. J Cardiothorac Vasc Anesth. 2014 Jun;28(3):810-8. doi: 10.1053/j.jvca.2013.11.001. Epub 2014 Mar 18. J Cardiothorac Vasc Anesth. 2014. PMID: 24656300 No abstract available.

3

Effects of high-dose fentanyl on fluid and vasopressor requirements after cardiac surgery.

Tuman KJ, Keane DM, Spiess BD, McCarthy RJ, Silins AI, Ivankovich AD. Tuman KJ, et al. Among authors: spiess bd. J Cardiothorac Anesth. 1988 Aug;2(4):419-29. doi: 10.1016/0888-6296(88)90221-9. J Cardiothorac Anesth. 1988. PMID: 17171925 Clinical Trial.

4

Pro: the practice of cardiac anesthesia has changed after the withdrawal of aprotinin.

Spiess BD. Spiess BD. J Cardiothorac Vasc Anesth. 2010 Oct;24(5):875-8. doi: 10.1053/j.jvca.2010.07.009. J Cardiothorac Vasc Anesth. 2010. PMID: 20869614 No abstract available.

5

Pro: autologous blood should be available for elective cardiac surgery.

Spiess BD. Spiess BD. J Cardiothorac Vasc Anesth. 1994 Apr;8(2):231-7. doi: 10.1016/1053-0770(94)90068-x. J Cardiothorac Vasc Anesth. 1994. PMID: 8204816 Review. No abstract available.

6

Safety and efficacy of shed mediastinal blood transfusion after cardiac surgery: a multicenter observational study. Multicenter Study of Perioperative Ischemia Research Group.

Body SC, Birmingham J, Parks R, Ley C, Maddi R, Shernan SK, Siegel LC, Stover EP, D'Ambra MN, Levin J, Mangano DT, Spiess BD. Body SC, et al. Among authors: spiess bd. J Cardiothorac Vasc Anesth. 1999 Aug;13(4):410-6. doi: 10.1016/s1053-0770(99)90212-4. J Cardiothorac Vasc Anesth. 1999. PMID: 10468253

7

Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes.

Royston D, Levy JH, Fitch J, Dietrich W, Body SC, Murkin JM, Spiess BD, Nadel A. Royston D, et al. Among authors: spiess bd. Anesth Analg. 2006 Nov;103(5):1082-8. doi: 10.1213/01.ane.0000238447.74029.f5. Anesth Analg. 2006. PMID: 17056936

8

Sufentanil-midazolam anesthesia for coronary artery surgery.

Tuman KJ, McCarthy RJ, el-Ganzouri AR, Spiess BD, Ivankovich AD. Tuman KJ, et al. Among authors: spiess bd. J Cardiothorac Anesth. 1990 Jun;4(3):308-13. doi: 10.1016/0888-6296(90)90036-f. J Cardiothorac Anesth. 1990. PMID: 1983403

9

Institutional variability in red blood cell conservation practices for coronary artery bypass graft surgery. Institutions of the MultiCenter Study of Perioperative Ischemia Research Group.

Stover EP, Siegel LC, Body SC, Levin J, Parks R, Maddi R, D'Ambra MN, Mangano DT, Spiess BD. Stover EP, et al. Among authors: spiess bd. J Cardiothorac Vasc Anesth. 2000 Apr;14(2):171-6. doi: 10.1016/s1053-0770(00)90013-2. J Cardiothorac Vasc Anesth. 2000. PMID: 10794337 Clinical Trial.

10

Hematologic changes in a patient with heparin-induced thrombocytopenia who underwent cardiopulmonary bypass after ancrod defibrinogenation.

Spiess BD, Gernsheimer T, Vocelka C, Chandler WL, Benak A, Joy JV, Wright I, Hofer BO. Spiess BD, et al. J Cardiothorac Vasc Anesth. 1996 Dec;10(7):918-21. doi: 10.1016/s1053-0770(96)80057-7. J Cardiothorac Vasc Anesth. 1996. PMID: 8969402 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page